We evaluated the performance of our automated computerized scheme for determining the likelihood of malignancy of pulmonary nodules on high-resolution computed tomography (HRCT) and positron emission tomography (PET) scans. Our database contained 36 primary lung cancers and 9 benign nodules. After the nodule location was identified by a radiologist, the boundary surface of the nodule was segmented automatically using a spiral-scanning technique. Objective nodular features were assessed by quantitative analysis of the nodular shape and on gray-level histograms of the interior and exterior regions. The likelihood of malignancy was determined by a support vector machine. The performance of our technique in distinguishing between benign and malignant nodules was evaluated by receiver operating characteristic (ROC) analysis. The area under the ROC curve (AUC) value obtained by using HRCT features alone was 0.87. The integration of PET features into the AUC value resulted in a significant improvement from 0.87 to 0.94 (P ＜ 0.01). The AUC value obtained from simultaneous selection of HRCT and PET features was 0.97. A statistically significant difference (P ＜ 0.01) was observed between the result obtained by simultaneous HRCT and PET feature selection (AUC ＝ 0.97) and that by integration of PET features (AUC ＝ 0.94). Our automated computerized scheme for determining the likelihood of malignancy may help radiologists to differentiate between benign and malignant pulmonary nodules on HRCT and PET scans.
Introduction
The leading cause of death in Japan is cancer. In 2012, 71, 518 (19.8％) of 360,963 cancer deaths, were attributable to lung cancerz1|. Therefore, early detection of lung cancers is important, as is the differentiation between benign and malignant pulmonary nodules. According to a review by El-Baz et al. z2|, many studies have addressed the computer-aided diagnosis (CAD) of lung cancer. In an earlier study, we applied a computerized scheme for determining the likelihood of malignancy of nodules visualized on chest radiographsz3|and low-dose CT scans z4|. Kawata et al. z5| characterized the morphology of small pulmonary nodules by surface curvature and ridge line, Way et al. z6| classified nodules as benign or malignant using a support vector machine (SVM) and stepwise feature selection, and Suzuki et al. z7|proposed a multiple massive training artificial neural network (MTANN) method that uses pixel values in a 9×9 subregion. We found that using CAD significantly improved the diagnostic accuracy of radiologistsz8|and posited that further research on CAD applicable to different diagnostic modalities is of clinical importance.
High-resolution CT (HRCT) and 18 F-fluorodeoxyglucose positron emission tomography ( 18 F-FDG PET) are the major techniques for the differential diagnosis of pulmonary nodules. However, the interpretation of these images relies on reader knowledge and experience. Many radiologists interpret HRCT scans empirically by referring to the morphological features of a nodule and subsequently obtain PET scans to identify functional features. Positing that simultaneous application of an easily understood CAD scheme would enhance the diagnostic performance of radiologists, we first analyzed our scheme using the morphological features visualized on HRCT scans and the image features identified by histogram analysis. Cases in which the differentiation between benign and malignant nodules was difficult were then analyzed based on their PET features. Lastly, the likelihood of malignancy of all pulmonary nodules was assessed by integrating the HRCT and PET findings and the usefulness of this technique was evaluated. Moreover, the likelihood of malignancy was determined by simultaneous selection of all HRCT and PET features and the results were compared with those obtained by integrating HRCT and PET findings.
Materials and Methods

Materials
Our database contained 36 primary lung cancers (24 adenocarcinomas, 5 squamous cell carcinomas, 3 adenosquamous carcinomas, 2 large cell carcinomas, 2 small cell carcinomas) and 9 benign nodules. One of the benign nodules was a chronic granulomatous inflammatory focus and the benign nature of the other 8 nodules was confirmed by the absence of changes (n=4) or a decrease in size (n=4) over the course of 3 years to less than a 3.0-cm maximum diameter. All 45 pulmonary nodules were solid nodules. Part-solid nodules were excluded from our study because they are associated with a high probability of malignancy and easily diagnosed. The 45 lesions were detected in 17 women and 28 men ranging in age from 28 to 83 years (median 65 years), and were diagnosed on HRCT and PET scans with slice thickness of 1.25 and 3.3 mm, respectively. Of the 45 patients, 25 were scanned with a LightSpeed 16-and the other 20 with a LightSpeed VCT instrument (GE Medical Systems, Milwaukee, WI). For acquisition of PET images, we used a Discovery ST scanner (GE Medical Systems) in all 45 patients. Figure 1 shows the distribution of the maximum standardized uptake value (SUVmax) of the nodules in our database. The SUVmax ranged from 0.8-7.0 for benign and from 2.3-13.1 for malignant nodules. The overlap ratio between benign and malignant nodules was 71.1％ (32/45). The sensitivity and specificity were 100％ and 33％, respectively, when SUVmax＝ 2, 86％ and 89％ when SUVmax＝ 2.7, and 25％ and 100％ when SUVmax＝ 7. Using bilinear interpolation, we converted all volume data acquired on HRCT and PET scans into isotropic voxels of 0.35 and 1.0 mm, respectively.
Our institutional review board approved this retrospective study and waived the requirement for patientsʼ informed consent. Figure 2 shows a solitary pulmonary nodule in the center of the volumes of interest (VOIs) with matrix size of 240×240×240 on a 12-bit gray scale. The center of the VOI corresponded to the center location of the nodule identified by the radiologist. The three-dimensional (3D) image was transformed into a two-dimensional (2D) image using a spiral scanning technique z9|. The L sample points with even spiral distribution on a spiralscanning line are displayed in Fig. 3 ; L was set empirically to 797. The 2D image was translated by aligning the voxel value on the radial lines of the sample points from the center of the VOI to the north (left side of Figs. 4a and b) and south poles (right side of Figs. 4a and b) . As shown in Fig. 4b , the border between the nodule and the background was determined by dynamic programming. Yuichiro Figures 4c-e are the axial, coronal, and sagittal views of the transformed 3D representations of the 2D segmented nodule region shown in Fig. 4b . Nodular spiculations were extracted with a lineenhancement filterz10|. The filter was applied to the 2D axial image containing the center of gravity of the segmented nodule region and to the 3D volume data (Fig.  5 ). Spiculations were defined as line components extending from the nodule region to within 5 mm outside this region.
Methods 2.2.1 Nodule segmentation and spiculation extraction
Feature extraction
We extracted 32 nodule features from HRCT scans and 12 features from PET scans. On HRCT scans, the effective diameter of a nodule region was defined as the diameter of a sphere with the same volume as that of the region. Sphericity was defined by the fraction of the overlap volume of the sphere with the nodule region. The degree of irregularity was defined by 1−S2/S1, where S1 is the voxel count of the region surface and S2 is the voxel count of the sphere surface with the same volume as the region. Ten features based on nodule spiculations were computed, 5 from the 2D axial image and 5 from its 3D volume data. The volume of spiculation, G, was defined by the voxel count of the spiculation. The spiculation ratio was computed by G/G+N, where N is the voxel count of the nodule region. Three features of the remainder were determined as the overlap ratio between the voxel count of the surface drawn on 1, 5, and 10 outside voxels (Fig. 6 ) and the voxel count of spiculations intersecting the surface, respectively.
The features we used were the mean voxel value, the standard deviation (SD), the voxel value at the peak, the peak value, the full width at half-maximum (FWHM) and at tenth maximum (FWTM), the skew, and the kurtosis on gray-level histograms of both the interior and exterior regions of the segmented nodules on HRCT scans and on SUV-level histograms of the volumes on PET scans. The length of the exterior region was 1/4 of the effective diameter. Differences between the voxel values at the peak, the mean voxel values, and the peak values on graylevel histograms of both the interior and exterior regions of the segmented nodules on HRCT scans were computed as contrast features. The mean relative frequency and the maximum and minimum values of SUV-level histograms of the volumes of the segmented nodules were determined on PET scans. The SUVmax recorded by the radiologist was evaluated.
Feature selection using the support vector
machine (SVM) of HRCT scans We used SVM z11| with Gaussian kernel for feature classification and leave-one-out cross-validation (LOOCV) to increase the versatility of our proposed method for training and testing the SVM. The value of soft margin used in the SVM was 128, which was determined empirically in this study. For training, we used all but one case in the database ; the unused case was submitted for testing of the trained SVM. This procedure was repeated until each case in the database was tested once. SVM separates benign from malignant nodules using a hyperplane in the feature space. The SVM output value represents the distance to the hyperplane indicating benignancy or malignancy. The SD of the distance is computed, and the discrimination boundary is set at 0.5. The SVM output value is linearly normalized as the likelihood of malignancy, so that one direction for benign nodules (0.5−1.96 SD) is 0.05, and another direction for malignant nodules (0.5+1.96 SD) is 0.95. Values less than 0.01 and greater than 0.99 were assigned values of 0.01 and 0.99, respectively. The performance of the automated computerized scheme was evaluated by receiver operating characteristic (ROC) analysis (LABROC4 program z12, 13|) ; the area under the ROC curve (AUC) was used as a measure of performance. Statistical significance was determined using the Wilcoxon signed-rank testz14|.
Our feature selection method comprised of four steps. First, a feature with the highest AUC value determined by SVM using LOOCV was identified. Second, one feature which when added resulted in the highest AUC value was searched and appended. Third, this procedure was repeated until all features were included in the combination. Lastly, the combination yielding the highest AUC Advanced Biomedical Engineering. Vol. 3, 2014. value at the lowest number of features was identified. Figure 7 shows changes in AUC value obtained by sequential addition of features. The highest AUC value at the lowest number of combined features (n ＝ 3) was 0.87. Figure 11a shows how AUC value changed as we added more features to all feature subsets. The distribution of the likelihood of malignancy obtained by simultaneous selection of HRCT and PET features is shown in Fig. 11b. 
Integration of PET
Simultaneous selection of HRCT and PET features
Results
In Fig. 12 and Table 1 , we present 3 ROC curves and their sensitivity and specificity, respectively. The results were obtained with HRCT features only, after integrating PET features to HRCT features, and by simultaneous selection Yuichiro The highest AUC value at the lowest number of combined features n=3 is 0.87. The 3 features were selected in the order of effective diameter, peak on gray-level histogram of the exterior region, and area of spiculation on 2D axial image. The AUC value obtained by simultaneous selection of HRCT and PET features was 0.97, for the following 8 features : the SD, the kurtosis on gray-level histogram of the interior region, the sphericity, the overlap ratio with 5 voxels outside on the 2D axial image from where we selected the HRCT features, the FWTM, the kurtosis, the mean relative frequency, and the SD of SUV-level histogram of PET features.
Discussion
The distribution of the likelihood of malignancy (Fig. 10) and the shape of the ROC curves (Fig. 12) show that the differentiation between benign and malignant nodules was improved by the addition of PET features. The ROC curve obtained by integrating HRCT and PET features showed a higher sensitivity at lower specificity than the ROC curve yielded from HRCT features alone. A rightward shift of the distribution of likelihood of malignancy assessed by SVM output was observed when integrated HRCT and PET features were used compared with HRCT features alone (Fig. 8) .
The AUC value obtained from simultaneous selection of HRCT and PET features (0.97) was greater than the AUC value obtained from HRCT features alone (0.87) and greater than that from integrated HRCT and PET features (0.94). The difference in performance was statistically significant (P ＜ 0.01) between AUC value obtained by simultaneous feature selection (AUC ＝ 0.97) and that by integrating HRCT and PET features (AUC ＝ 0.94). We confirmed that significant improvement was obtained when the PET features were included. Meanwhile, the reason for crossing ROC curves is due to the Advanced Biomedical Engineering. Vol. 3, 2014. increase of benign larger than the minimum of malignant, as shown in Figs. 8 and 10 . It is necessary to select the method carefully. Figure 13 shows the relationship between two features for benign and malignant nodules in our database. Although there is a considerable overlap between benign and malignant nodules, the performance results indicate the potential usefulness for distinguishing between benign and malignant nodules. Figure 13a shows the relationship between the FWTM and the kurtosis on SUV-level histogram (both PET features). The FWTM for malignant nodules tends to be greater than that for benign lesions. Figure 13b shows the relationship between the SD on gray-level histogram of the interior region (HRCT feature) and the mean relative frequency on SUV-level histogram (PET feature). The SD of benign nodules tends to be near the center than that of malignant lesions, and the mean relative frequency of malignant nodules tends to be lower than that of benign lesions.
There was a significant difference in the distribution of the likelihood of malignancy. The performance indicated by AUC value obtained by simultaneous feature selection was significantly different from that by integrating HRCT and PET features. This observation has clinical implications and demands explanation. Although our database contained only a small number of nodules (9 benign and 36 malignant) at present, by re-selecting the available differential features as the database expands, we consider that our technique is versatile.
Radiologists identify a variety of nodular morphologies. The morphological features we selected on HRCT scans were the effective nodular diameter and the area of spiculation on 2D axial images. Other morphological features may be more appropriate for the differentiation between benign and malignant nodules, and we are in the process of identifying additional useful features.
We propose that our scheme that uses both morphological features extracted from HRCT scans and functional features computed from PET scans improves the ability to distinguish between benign and malignant pulmonary nodules. Observer studies are under-way to evaluate the applicability of our method. Preliminary results showed that our scheme significantly improved the diagnostic performance of radiology residents in assessing malignancy of pulmonary nodules (p=0.02) but not of boardcertificated radiologists (p=0.62). We plan to analyze the distribution of the likelihood of malignancy, to assess the versatility of our computerized method by applying it to a larger dataset, and to identify specific features that assist in the differentiation between benign and malignant nodules. 
